CPR 1.1. Identifying Patients and Initiating Evaluation

Slides:



Advertisements
Similar presentations
The Epidemiology of Hemoglobin Levels in Patients With Type 2 Diabetes
Advertisements

Robert C. Stanton, MD  American Journal of Kidney Diseases 
Chronic Kidney Disease in Diabetes
2017 Annual Data Report Healthy People 2020.
Renal Function Testing
2018 Annual Data Report Volume 3: Healthy People 2020
American Journal of Kidney Diseases 
Spectrum and Burden of Erythropoiesis-Stimulating Agent Hyporesponsiveness Among Contemporary Hemodialysis Patients  Jiacong Luo, MD, MS, MPH, Donna E.
Douglas S. Fuller, MS, Ronald L. Pisoni, PhD, MS, Brian A
Peritoneal dialysis American Journal of Kidney Diseases
Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and.
Metabolic Complications in Elderly Adults With CKD
Volume 2: End-Stage Renal Disease
Association of Physical Activity and Renal Function in Subjects With and Without Metabolic Syndrome: A Review of the Third National Health and Nutrition.
World Kidney Day 2014: CKD and the Aging Population
Volume 72, Issue 5, Pages (September 2007)
Prenatal Growth and CKD in Older Adults: Longitudinal Findings From the Helsinki Birth Cohort Study,   Johan G. Eriksson, Minna K. Salonen, Eero.
Impact of Comorbidities on Mortality in Managed Care Patients With CKD
Management of Acute Kidney Injury: Core Curriculum 2018
GFR Estimation: From Physiology to Public Health
Andrew Narva  American Journal of Kidney Diseases 
Advances in CKD Detection and Determination of Prognosis: Executive Summary of the National Kidney Foundation–Kidney Early Evaluation Program (KEEP) 2012.
I. Introduction American Journal of Kidney Diseases
Focusing on Health Literacy Might Help Us Cross the Quality Chasm
Hemodialysis Facility Variation in Hospitalization and Transfusions Using Medicare Claims: The DOPPS Practice Monitor for US Dialysis Care  Douglas S.
Meeting the challenges of the new K/DOQI guidelines
Erratum American Journal of Kidney Diseases
National Kidney Foundation  American Journal of Kidney Diseases 
Glycemic Management in ESRD and Earlier Stages of CKD
Chapter 2: Use of iron to treat anemia in CKD
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
The DOPPS Practice Monitor for US Dialysis Care: Update on Trends in Anemia Management 2 Years Into the Bundle  Douglas S. Fuller, MS, Ronald L. Pisoni,
The Kidney Early Evaluation Program (KEEP): Program Design and Demographic Characteristics of the Population  Claudine T. Jurkovitz, MD, MPH, Yang Qiu,
Robert C. Stanton, MD  American Journal of Kidney Diseases 
American Journal of Kidney Diseases
Anemia management for hemodialysis patients: Kidney Disease Outcomes Quality Initiative (K/DOQI) guidelines and Dialysis Outcomes and Practice Patterns.
Clinical Practice Guidelines for Vascular Access
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
American Journal of Kidney Diseases
Andrew D. Howard, MD, Robin S. Howard, MA, Stuart L
A Decade After the KDOQI CKD Guidelines: A Perspective From Mexico
High Prevalence and Low Awareness of CKD in Taiwan: A Study on the Relationship Between Serum Creatinine and Awareness From a Nationally Representative.
Michael F. Flessner, MD, PhD, Sharon B. Wyatt, PhD, Ermeg L
Kidney Disease Among African Americans: A Population Perspective
CPR 1.2.: Evaluation of Anemia in CKD
Beef Tea, Vitality, Creatinine, and the Estimated GFR
A Timely Evaluation of the Psychometric Properties of the KDQOL-36
Distribution of Measured GFR in Apparently Healthy Chinese Adults
Volume 68, Issue 6, Pages (December 2005)
Prevalence and Severity of Renal Disease in Familial Dysautonomia
American Journal of Kidney Diseases
Study Designs in Patient-Oriented Research
Erratum American Journal of Kidney Diseases
Daniel E. Weiner, MD, MS, Mark J. Sarnak, MD, MS 
Lesley A. Stevens, MD, MS, Nicholas Stoycheff, MD 
KDOQI Clinical Practice Guideline and Clinical Practice Recommendations for Anemia in Chronic Kidney Disease: 2007 Update of Hemoglobin Target    American.
Lynda Anne Szczech, Ira L. Lazar  Kidney International 
Lesley A. Stevens, MD, MS, Josef Coresh, MD, PhD, Andrew S. Levey, MD 
Erratum American Journal of Kidney Diseases
Hypertension and CKD: Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES),   Madhav V. Rao,
The Use of Vaccines in Adult Patients With Renal Disease
Arteriovenous fistula creation: should US nephrologists get involved?
Chi-Yuan Hsu, M.D., M.Sc., Glenn M. Chertow, Gary C. Curhan 
Supportive care for patients with renal disease: Time for action
Ann M. O'Hare, MA, MD  American Journal of Kidney Diseases 
Serum Leptin and Epoetin Sensitivity
Clinical Practice Recommendations For Peritoneal Dialysis Adequacy
Maristela Böhlke, PhD  American Journal of Kidney Diseases 
Clinical Practice Guidelines for Peritoneal Dialysis Adequacy
Jacob J.E. Koopman, MD, PhD  American Journal of Kidney Diseases 
Presentation transcript:

CPR 1.1. Identifying Patients and Initiating Evaluation   American Journal of Kidney Diseases  Volume 47, Pages S17-S27 (May 2006) DOI: 10.1053/j.ajkd.2006.03.012 Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 3 Relationship between Hb level and eGFR. Data represent a cross-sectional survey of individuals randomly selected from the general US population (NHANES III). Median and 95% confidence limits around the 95th and 5th percentiles are shown for males and females at each eGFR interval. Adapted with permission.27 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 4 Relationship between eGFR and prevalence of anemia as defined by differing Hb levels for (A) males and (B) females. Data from NHANES III. Reprinted with permission.27 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 5 Prevalence of anemia by CKD stage. Anemia, defined as an Hb level less than 13.0 g/dL in males and less than 12.0 g/dL in females, was plotted by stage of CKD in results from NHANES III compared with NHANES IV. USRDS 2004.28 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 6 Relationship between level of renal function, reflected by SCr level or GFR, and prevalence of anemia, defined at different Hb cutoff levels, among patients under the care of physicians. Reprinted with permission.29 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 7 Hb percentiles by GFR in the Canadian Multicentre Longitudinal Cohort Study. Patients were referred to nephrologists between 1994 and 1997. Results shown exclude patients receiving ESA therapy or with an arteriovenous fistula. Reprinted with permission.4,30 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 8 Prevalence of low Hb level by category of GFR in the Canadian Multicentre Longitudinal Cohort Study. Reprinted with permission.4,30 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 9 Prevalence of low Hb level by eGFR in patients with diabetes compared with the general population. Open circles (○) indicate the diabetic population, while closed circles (●) represent general population data from NHANES III. A: Hb ≤11 g/dL; B: WHO criteria (men, Hb <13 g/dL; women, Hb <12 g/dL). Reprinted with permission.35 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 10 Changes in Hb levels and eGFR over 2 years in adult patients with CKD stages 3 and 4 not treated with ESA. Oral iron supplements and occasional IV iron treatment were administered to maintain TSAT at greater than 20% and ferritin levels greater than 100 ng/mL. Data given as mean ± SD. Although mean Hb levels showed little or no change, the number of study patients remaining without ESA therapy declined. Results courtesy of the authors, from control group patients previously described. Reprinted with permission.39 American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions

Fig 11 Distribution of Hb levels in adult males and females by age group. The 5th, 50th, and 95th percentiles are shown for each age group. In females, results reflect only individuals with serum ferritin greater than 25 ng/mL or TSAT greater than 16% because lower values may contribute to low Hb levels. Dash-dot-dash lines indicate recommended cutoff value to define anemia. (Source: US Renal Data System [USRDS] special data request, NHANES 1999-2002 data set). American Journal of Kidney Diseases 2006 47, S17-S27DOI: (10.1053/j.ajkd.2006.03.012) Copyright © 2006 National Kidney Foundation, Inc. Terms and Conditions